Kontour Medical released its 2024 annual performance, with a net profit attributable to the parent company of 88.4 million yuan, a year-on-year increase of 17.07%

Kontour Medical released its 2024 annual performance, achieving revenue of 322 million yuan during the reporting period, a year-on-year increase of 17.06%; the net profit attributable to shareholders was 88.4 million yuan, a year-on-year increase of 17.07%. The company plans to distribute a cash dividend of 1.8 yuan for every 10 shares to all shareholders. The core products in neurosurgery performed outstandingly, with total revenue from PEEK materials and titanium materials reaching 278.0188 million yuan, accounting for 89.19% of the main business income. The company continues to optimize its products through technological innovation, consolidating its leading position in the field of neurosurgical repair and fixation